Site Search

... grassroots, and communications resources to Boost government funding for lifesaving cancer research; Expand access to adequate, affordable health care for people with cancer and their families; Ensure that proven preventive screenings such as mammograms and colonoscopies are available to ...

... quickly and publicly. When you click the below button, you'll be directed to a Facebook post about this announcement on the U.S. Department of Health and Human Services Facebook page.  That department - led by Secratary Azar - is responsible for seeing this through. Please add a brief ...

... that they are generally larger, more complex molecules. Biologics are usually administered via injection or infusion. Most biologics in cancer care are given under the close supervision of a medical professional.   Q. What is a biosimilar? Answer: A biosimilar is a biologic product ... strength as its reference product.  Q. Why does the biosimilar pathway exist? Answer: Biologics have become an increasingly important part of health care. With the increasing attention to the costs of drugs, it became apparent that there was a need to create competition and choice that ... Your healthcare provider may have various reasons for selecting a branded biologic or biosimilar, including experience with the product, your health plan’s formulary (permitted drugs), patient preference, cost consciousness, or some combination of these factors. You should ask your ...

... Elizabeth J. Cathcart-Rake, M.D., Mayo Clinic, Jasmine Gowarty, M.D., Texas Oncology, Jessica Gilbertson, National Council for Urban Indian Health, Keeshia Jones, Sisters Network, Inc. & ABCD, Sunaina Mathur, Cancer Stompers, Flecia Brown, ACS CAN Georgia Lead Volunteer, Ashton ... is Being Left Behind – Why Aren’t They Included in Clinical Trials?” to discuss the Black community’s unique challenges to cancer care.  Watch the recording Download the Fireside Chat Program   Clinical Trials: Why Black Community Participation Matters Dr. Sara Horton, ... Horton demystifies common misconceptions about clinical trials and how increasing Black patients enrollment in trials improves the standard of care for everyone.   BVC In Action ...